January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreDecember 30, 2025
Market insights predict the global bone & joint health supplements industry will increase from USD 15.01 billion in 2025 to USD 34.04 billion by 2035, achieving a CAGR of 8.54%. The bone & joint health supplements market is growing due to rising osteoporosis cases. North America is leading the way due to rising arthritis cases....
December 30, 2025
According to market projections, the global head & neck cancer therapeutics market, valued at USD 2.65 billion in 2025, is anticipated to reach USD 8.14 billion by 2035, growing at a CAGR of 11.87% over the next decade. A surge in tobacco and alcohol consumption and the rising cases of HPV are impacting the global expansion. North America regis...
December 30, 2025
Market insights predict, the human platelet lysate industry is expected to grow from USD 587 million in 2025 to USD 2416 million by 2035, driven by a CAGR of 15.19%. The human platelet lysate market is growing due to the rising usage in developing cell therapy and other biopharmaceuticals. North America is leading the way due to the rising demand f...
December 30, 2025
According to forecasts, the global antithrombin market will grow from USD 420.33 million in 2025 to USD 640.37 million by 2035, with an expected CAGR of 4.3%. The antithrombin market is driven by technological advancements across the various steps involved in its production. North America is leading the market due to the strong presence of the phar...
December 30, 2025
According to forecasts, the global hemorrhoids treatment market will grow from USD 1.21 billion in 2025 to USD 2.18 billion by 2035, with an expected CAGR of 6.05%. The rising incidence of hemorrhoids and the increasing minimally invasive procedures drive the market. North America dominated the global market due to a robust healthcare infrastructur...
December 30, 2025
The growing demand for outsourcing services and the increasing development of complex products drive the global market. North America dominated the global market due to a robust manufacturing infrastructure and the presence of key players....
December 30, 2025
According to market projections, the sulfonamides market was valued at USD 1.91 billion in 2025 and is projected to grow from USD 1.97 billion in 2026 to USD 2.7 billion by 2035, registering a CAGR of 3.54% during the forecast period. The sulfonamides market report provides detailed coverage of product types, applications, routes of administration,...
December 30, 2025
The next-generation metabolic therapies market is witnessing strong expansion and is expected to generate revenue in the hundreds of millions during the forecast period from 2026 to 2035, driven by rising cases of metabolic disorders such as obesity, diabetes, NAFLD/NASH, and cardiometabolic syndrome....
December 30, 2025
Projections indicate that, heart rate monitor market was valued at USD 2.74 billion in 2025, increased to USD 2.96 billion in 2026, and is projected to reach USD 5.84 billion by 2035, growing at a CAGR of 7.87% from 2026 to 2035. This report provides comprehensive coverage of market size, historical and forecast data, segmentation by product type, ...
December 29, 2025
According to market projections, the dental services sector is expected to grow from USD 493 billion in 2025 to USD 810.73 billion by 2035, seeing growth due to increased awareness of oral health, rising demand for cosmetic procedures, and advancements in dental technology. Trends include tele-dentistry, minimally invasive treatments, and a focus o...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com